P426 In failure of non-optimised adalimumab (ADA) with...

P426 In failure of non-optimised adalimumab (ADA) with therapeutic serum levels, a change in biotherapy class is greater than an intensification of ADA dose in IBD patients

Roblin, X, genin, C, williet, N, veyrard, P, boschetti, G, berger, A E, flourie, B, nancey, S, Paul, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.555
Date:
January, 2020
File:
PDF, 294 KB
2020
Conversion to is in progress
Conversion to is failed